Published in J Cardiovasc Pharmacol on January 01, 1999
Enhanced atherosclerosis and kidney dysfunction in eNOS(-/-)Apoe(-/-) mice are ameliorated by enalapril treatment. J Clin Invest (2000) 1.84
Elevation of the antifibrotic peptide N-acetyl-seryl-aspartyl-lysyl-proline: a blood pressure-independent beneficial effect of angiotensin I-converting enzyme inhibitors. Fibrogenesis Tissue Repair (2011) 0.87
Renal failure in mice with Gsalpha deletion in juxtaglomerular cells. Am J Nephrol (2010) 0.87
Role of angiotensin converting enzyme inhibitors and angiotensin receptor blockers in hypertension of chronic kidney disease and renoprotection. Study results. Hippokratia (2011) 0.86
Prednisolone co-administered with losartan confers renoprotection in patients with IgA nephropathy. Ren Fail (2007) 0.80
The biological significance of angiotensin-converting enzyme inhibition to combat kidney fibrosis. Clin Exp Nephrol (2014) 0.77
Optimising nutrition in chronic renal insufficiency--progression of disease. Pediatr Nephrol (2004) 0.77
Postmarketing surveillance study of benazepril in chinese patients with hypertension: An open-label, experimental, epidemiologic study. Curr Ther Res Clin Exp (2004) 0.75
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med (2001) 17.24
Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA (2001) 8.80
Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data. Ann Intern Med (2001) 6.22
Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med (1996) 5.46
The Heidelberg classification of renal cell tumours. J Pathol (1997) 5.36
Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group. N Engl J Med (1997) 4.71
Corticosteroids in IgA nephropathy: a randomised controlled trial. Lancet (1999) 3.51
The nephrotic syndrome. N Engl J Med (1998) 3.22
End-stage renal failure in type 2 diabetes: A medical catastrophe of worldwide dimensions. Am J Kidney Dis (1999) 3.00
Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood (2001) 2.99
Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet (1998) 2.98
Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis (2001) 2.42
Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS) Blood (1997) 2.40
Hantavirus infection presenting as acute renal failure. Lancet (1990) 2.40
Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant (2000) 2.38
Controlled trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1984) 2.26
Validation of a predictive model of idiopathic membranous nephropathy: its clinical and research implications. Kidney Int (1997) 2.17
The rising tide of endstage renal failure from diabetic nephropathy type II--an epidemiological analysis. Nephrol Dial Transplant (1995) 2.06
Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest (1989) 1.98
Ace inhibition in chronic renal failure: a step forward. Nephrol Dial Transplant (1996) 1.96
Cyclosporin in idiopathic glomerular disease associated with the nephrotic syndrome : workshop recommendations. Kidney Int (2007) 1.86
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. Diabetes Care (1999) 1.86
Fludarabine, cyclophosphamide and anti-thymocyte globulin for alternative donor transplants in acquired severe aplastic anemia: a report from the EBMT-SAA Working Party. Bone Marrow Transplant (2005) 1.86
Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Studies 82, 87, 88, 91 and 95 for childhood acute lymphoblastic leukemia. Leukemia (2009) 1.86
Gender-specific association of adiponectin as a predictor of progression of chronic kidney disease: the Mild to Moderate Kidney Disease Study. Kidney Int (2007) 1.83
A randomized trial of methylprednisolone and chlorambucil in idiopathic membranous nephropathy. N Engl J Med (1989) 1.83
Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group. Lancet (1991) 1.82
Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy. The Italian Idiopathic Membranous Nephropathy Treatment Study Group. N Engl J Med (1992) 1.81
Insulin resistance and hyperinsulinemia are already present in patients with incipient renal disease. Kidney Int (1998) 1.77
A 10-year follow-up of a randomized study with methylprednisolone and chlorambucil in membranous nephropathy. Kidney Int (1995) 1.74
Safety of ultrasound-guided percutaneous renal biopsy-retrospective analysis of 1090 consecutive cases. Nephrol Dial Transplant (1998) 1.71
ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States. Kidney Int (1996) 1.71
Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer. J Clin Oncol (1994) 1.67
Treatment of microalbuminuria in hypertensive subjects with elevated cardiovascular risk: results of the IMPROVE trial. Kidney Int (2007) 1.67
Differences in incidence of reported asthma related to age in men and women. A retrospective analysis of the data of the European Respiratory Health Survey. Am J Respir Crit Care Med (2000) 1.66
Prospective monitoring of polyomavirus BK replication and impact of pre-emptive intervention in pediatric kidney recipients. Am J Transplant (2007) 1.61
Disturbed calcium metabolism in subjects with elevated diastolic blood pressure. Clin Investig (1992) 1.61
Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int (1998) 1.61
Evidence for impaired hepatic vitamin K1 metabolism in patients treated with N-methyl-thiotetrazole cephalosporins. Thromb Haemost (1984) 1.59
Optimization of in vitro expansion of human multipotent mesenchymal stromal cells for cell-therapy approaches: further insights in the search for a fetal calf serum substitute. J Cell Physiol (2007) 1.57
Reversible acute renal failure from gross haematuria due to glomerulonephritis: not only in IgA nephropathy and not associated with intratubular obstruction. Nephrol Dial Transplant (1995) 1.57
Liver transplantation in children less than 1 year of age. J Pediatr (1990) 1.55
Failure of arginine-vasopressin and other pressor hormones to increase in severe recurrent dialysis hypotension. Nephrol Dial Transplant (1995) 1.54
The Kidney Disease: improving Global Outcomes website: comparison of guidelines as a tool for harmonization. Kidney Int (2007) 1.53
Size reduction of the donor liver is a safe way to alleviate the shortage of size-matched organs in pediatric liver transplantation. Ann Surg (1990) 1.50
Parathyroidectomy in patients on renal replacement therapy: an epidemiologic study. J Am Soc Nephrol (2001) 1.49
Isotretinoin alleviates renal damage in rat chronic glomerulonephritis. Kidney Int (2001) 1.49
"Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. Kidney Int (1996) 1.49
In situ production of TNF-alpha, IL-1 beta and IL-2R in ANCA-positive glomerulonephritis. Kidney Int (1993) 1.49
Intradialytic calcium balances with different calcium dialysate levels. Effects on cardiovascular stability and parathyroid function. Nephron (1996) 1.48
Tissue factor antigen is elevated in patients with microvascular complications of diabetes mellitus. Exp Clin Endocrinol Diabetes (1997) 1.48
Oral valganciclovir as preemptive therapy for cytomegalovirus infection post allogeneic stem cell transplantation. Transpl Infect Dis (2007) 1.48
Rapidly progressive IgA nephropathy with anti-myeloperoxidase antibodies benefits from immunosuppression. Clin Nephrol (1997) 1.48
Poplar lignin decomposition by gram-negative aerobic bacteria. Appl Environ Microbiol (1981) 1.47
Practical guidelines for the use of NESP in treating renal anaemia. Nephrol Dial Transplant (2001) 1.47
Clinical severity and molecular typing of human rhinovirus C strains during a fall outbreak affecting hospitalized patients. J Clin Virol (2009) 1.47
A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int (1993) 1.46
High prevalence of silent gallstone disease in dialysis patients. Nephron (1994) 1.45
Bartonella-related pseudomembranous angiomatous papillomatosis of the oral cavity associated with allogeneic bone marrow transplantation and oral graft-versus-host disease. Br J Dermatol (2007) 1.44
Trends in the prevalence of asthma and allergic rhinitis in Italy between 1991 and 2010. Eur Respir J (2011) 1.44
Evaluation of clinical guidelines for the management of end-stage renal disease in europe: the EU BIOMED 1 study. Nephrol Dial Transplant (2000) 1.43
Genesis and significance of hypertension in autosomal dominant polycystic kidney disease. Nephron (1994) 1.42
Long-term dialysis with low-calcium solution (1.0 mmol/L) in CAPD: effects on bone mineral metabolism. Collaborators of the Multicenter Study Group. Perit Dial Int (1996) 1.42
The concept and technique of the split liver in clinical transplantation. Surgery (1990) 1.41
The response of GFR to amino acids differs between autosomal dominant polycystic kidney disease (ADPKD) and glomerular disease. Nephrol Dial Transplant (1992) 1.41
Parathyroidectomy in secondary (renal) hyperparathyroidism--whom, when, how? Int J Artif Organs (1993) 1.41
Clinical management of myelodysplastic syndromes: update of SIE, SIES, GITMO practice guidelines. Leuk Res (2010) 1.40
[Type II diabetes. Pathophysiology of insulin resistance, rules and goals of therapy]. Dtsch Med Wochenschr (1995) 1.40
Horseshoe kidney. Nephrol Dial Transplant (1999) 1.40
Gitelman syndrome: pathophysiological and clinical aspects. QJM (2010) 1.39
Microscopic hematuria diagnosis and management. Nephron (1996) 1.39
The reconstitution of cellular immunity after bone marrow transplantation in children. Haematologica (1992) 1.39
Comparison of three different tests for assessment of hepatitis C virus in dialysis patients. Perit Dial Int (1995) 1.39
[Health economic consequences of the use of irbesartan in patients in Germany with type 2 diabetes, nephropathy and hypertension]. Dtsch Med Wochenschr (2004) 1.39
Night time blood pressure in diabetic patients--the submerged portion of the iceberg? Nephrol Dial Transplant (1999) 1.39
[Routine screening for microalbuminemia in type 2 diabetes mellitus--pro]. Dtsch Med Wochenschr (2003) 1.39
Programmed bone-marrow donor for a leukaemic sibling, 10 years on. Lancet (1997) 1.39
Rapidly progressive glomerulonephritis in a patient with Henoch-Schoenlein purpura. Spontaneous recovery of renal function after six months of maintenance hemodialysis. Clin Nephrol (1995) 1.39
Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am J Transplant (2007) 1.39
Is control of secondary hyperparathyroidism optimal with the currently used calcium concentration in the CAPD fluid? Nephrol Dial Transplant (1991) 1.38
Peripheral blood mononuclear cells isolated from patients with diabetic nephropathy show increased activation of the oxidative-stress sensitive transcription factor NF-kappaB. Diabetologia (1999) 1.38
Natriuretic factors and lithium clearance in patients with the syndrome of inappropriate antidiuretic hormone (SIADH) Eur J Clin Invest (1989) 1.38
Sinus histiocytosis with massive lymphoadenopathy (Rosai-Dorfman disease). Clinico-pathological analysis of a paediatric case. Eur J Pediatr (1992) 1.38
Analgesic nephropathy. Nephrol Dial Transplant (1996) 1.38
[The quality of the treatment of diabetics in kidney failure in Germany]. Dtsch Med Wochenschr (2000) 1.38
Regulation of base balance in bicarbonate hemofiltration. Int J Artif Organs (1994) 1.38
Physiological doses of calcium regulatory hormones do not normalize bone cells in uraemic rats. Eur J Clin Invest (1999) 1.38